Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor (Q56568324)

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Strategies for immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

How much longer will tumour cells fool the immune system?

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Cancer antigens: immune recognition of self and altered self

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Induction of anti-self-immunity to cure cancer

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Tolerance and cancer: a critical issue in tumor immunology.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Specific cytotoxic T lymphocytes in gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Immunotherapy with T cells bearing chimeric antitumor receptors

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Signaling defects in T lymphocytes of patients with malignancy

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

CD28/B7 system of T cell costimulation

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

CD28: a signalling perspective.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

CD28/B7 costimulation: a review

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Functional expression of chimeric receptor genes in human T cells

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Costimulatory approaches to adoptive immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Eradication of established tumors by CD8+ T cell adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Tumor size at the time of adoptive transfer determines whether tumor rejection occurs

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Retroviral-mediated gene transfer in primary murine and human T-lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021

Human T lymphocyte genetic modification with naked DNA.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0102-70

7 January 2021